MedTrace Logo

Vitamin D Supplementation in Crohn's Patients

NCT00742781 · Status: COMPLETED · Phase: PHASE1 · Type: INTERVENTIONAL · Enrollment: 21

Last updated 2013-07-26

Study results available
· View outcomes & findings →

Summary

The purpose of this study is to determine the effect of vitamin D supplementation in Crohn's disease patients. Patients will be evaluated for increases in circulating vitamin D levels and effects on health benefits including improved bone markers, Crohn's disease activity scores, and inflammatory markers.

Conditions

Interventions

DIETARY_SUPPLEMENT

Vitamin D

Oral supplementation daily with up to 5000 IU over 6 months.

Sponsors & Collaborators

  • Penn State University

    lead OTHER

Principal Investigators

  • Margherita T Cantorna, PhD · Penn State University

Study Design

Allocation
NA
Purpose
SUPPORTIVE_CARE
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Max Age
70 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2009-05-31
Primary Completion
2011-08-31
Completion
2011-12-31

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00742781 on ClinicalTrials.gov